ALINT Share Price

Open 2.68 Change Price %
High 2.68 1 Day 0.02 0.76
Low 2.63 1 Week -0.08 -2.93
Close 2.65 1 Month -0.29 -9.86
Volume 24182 1 Year -0.50 -15.87
52 Week High 4.29
52 Week Low 2.55
ALINT Important Levels
Resistance 2 2.70
Resistance 1 2.68
Pivot 2.65
Support 1 2.62
Support 2 2.60
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
ALALO 0.09 28.57%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
AF 12.37 -8.23%
More..
EPA France Top Gainers Stocks
MLAMY 2.50 8233.33%
ALALO 0.09 28.57%
APAM 33.78 15.72%
APAM 33.78 15.72%
MLLOI 3.80 15.15%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
ALIMO 0.20 -28.57%
MLSAT 4.40 -18.97%
HCO 5.66 -12.38%
MLTRC 7.40 -9.87%
AF 12.37 -8.23%
AF 12.37 -8.23%
AF 12.37 -8.23%
AF 12.37 -8.23%
MLNMA 0.55 -6.78%
ALCLS 22.68 -6.78%
More..

Integragen (EPA: ALINT)

ALINT Technical Analysis 5
As on 20th Jul 2017 ALINT Share Price closed @ 2.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.06 & Strong Sell for SHORT-TERM with Stoploss of 3.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
ALINT Target for July
1st Target up-side 3.16
2nd Target up-side 3.27
3rd Target up-side 3.38
1st Target down-side 2.86
2nd Target down-side 2.75
3rd Target down-side 2.64
ALINT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.integragen.fr
ALINT Address
ALINT
Genopole Campus 1 - Genavenir 8
5 rue Henri Desbru
Evry, 91000
France
Phone: 33 1 60 91 09 00
Fax: 33 1 60 77 79 10
ALINT Latest News
Interactive Technical Analysis Chart Integragen ( ALINT EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Integragen
ALINT Business Profile
IntegraGen S.A. develops molecular diagnosis tests to identify treatments for pathologies in France. The company develops biomarkers for use as diagnostic tools in the fields of autism, oncology, diabetes, and obesity. It offers DNA extraction, sample management, and storage services; NextGen sequencing services; SNP genotyping services; and methylation analysis, which include DNA sample reception and QC, bisulfite conversion, genotyping analysis, data quality control, delivery of methylation value, and delivery of genome studio project file for data analysis with genome studio software. The company was founded in 2001 and is headquartered in Evry, France.